[1]
|
Mcneal, J.E. (1981) The Zonal Anatomy of the Prostate. The Prostate, 2, 35-49.
https://doi.org/10.1002/pros.2990020105
|
[2]
|
Berry, S.J., Coffey, D.S., Walsh, P.C. and Ewing, L.L. (1984) The Development of Human Benign Prostatic Hyperplasia with Age. The Journal of Urology, 132, 474-479. https://doi.org/10.1016/S0022-5347(17)49698-4
|
[3]
|
Wei, J.T., Calhoun, E. and Jacobsen, S.J. (2005) Urologic Diseases in America Project: Benign Prostatic Hyperplasia. The Journal of Urology, 173, 1256-1261. https://doi.org/10.1097/01.ju.0000155709.37840.fe
|
[4]
|
Parsons, J.K. (2010) Benign Prostatic Hyperplasia and Male Lower Urinary Tract Symptoms: Epidemiology and Risk Factors. Current Bladder Dysfunction Reports, 5, 212-218. https://doi.org/10.1007/s11884-010-0067-2
|
[5]
|
Litman, H.J. and McKinlay, J.B. (2007) The Future Magnitude of Urological Symptoms in the USA: Projections Using the Boston Area Community Health Survey. BJU International, 100, 820-825.
https://doi.org/10.1111/j.1464-410X.2007.07018.x
|
[6]
|
Lee, A.J., Garraway, W.M., Simpson, R.J., Fisher, W. and King, D. (1998) The Natural History of Untreated Lower Urinary Tract Symptoms in Middle-Aged and Elderly Men over a Period of Five Years. European Urology, 34, 325-332. https://doi.org/10.1159/000019749
|
[7]
|
Vos, T., Flaxman, A.D., Naghavi, M., et al. (2012) Years Lived with Disability (YLDs) for 1160 Sequelae of 289 Diseases and Injuries 1990-2010: A Systematic Analysis for the Global Burden of Disease Study 2010. Lancet, 380, 2163-2196. https://doi.org/10.1016/S0140-6736(12)61729-2
|
[8]
|
Egan, K.B. (2016) The Epidemiology of Benign Prostatic Hyperplasia Associated with Lower Urinary Tract Symptoms: Prevalence and Incident Rates. The Urologic Clinics of North America, 43, 289-297.
https://doi.org/10.1016/j.ucl.2016.04.001
|
[9]
|
Patel, N.D. and Parsons, J.K. (2014) Epidemiology and Etiology of Benign Prostatic Hyperplasia and Bladder Outlet Obstruction. Indian Journal of Urology, 30, 170-176. https://doi.org/10.4103/0970-1591.126900
|
[10]
|
Lee, R.K., Chung, D., Chughtai, B., Te, A.E. and Kaplan, S.A. (2012) Central Obesity as Measured by Waist Circumference is Predictive of Severity of Lower Urinary Tract Symptoms. BJU International, 110, 540-545.
https://doi.org/10.1111/j.1464-410X.2011.10819.x
|
[11]
|
Parikesit, D., Mochtar, C.A., Umbas, R. and Hamid, A.R.A.H. (2016) The Impact of Obesity towards Prostate Diseases. Prostate International, 4, 1-6. https://doi.org/10.1016/j.prnil.2015.08.001
|
[12]
|
Nickel, J.C. (2008) Inflammation and Benign Prostatic Hyperplasia. The Urologic Clinics of North America, 35, 109-115.
https://doi.org/10.1016/j.ucl.2007.09.012
|
[13]
|
Abdul-Muhsin, H.M., Jakob, N.J., McLemore, R.M., McAdams, S.B. and Humphreys, M.R. (2016) Infectious Complications Associated with the Use of Temporary Prostatic Urethral Stents in Patients with Benign Prostatic Hyperplasia. The Canadian Journal of Urology, 23, 8465-8470. https://pubmed.ncbi.nlm.nih.gov/27705732/
|
[14]
|
Rand, H.W. (1895) A Contribution to the Surgery of the Hyper-trophied Prostate. Annals of Surgery, 22, 217-225.
https://doi.org/10.1097/00000658-189507000-00020
|
[15]
|
Lee, C., Kozlowski, J.M. and Grayhack, J.T. (1997) In-trinsic and Extrinsic Factors Controlling Benign Prostatic Growth. The Prostate, 31, 131-138.
https://doi.org/10.1002/(SICI)1097-0045(19970501)31:2<131::AID-PROS9>3.0.CO;2-Q
|
[16]
|
Bruchovsky, N., Lesser, B., Van Doorn, E. and Craven, S. (1976) Hormonal Effects on Cell Proliferation in Rat Prostate. Vitamins & Hormones, 33, 61-102. https://doi.org/10.1016/S0083-6729(08)60951-6
|
[17]
|
Wilson, J.D. (1980) The Pathogene-sis of Benign Prostatic Hyperplasia. The American Journal of Medicine, 68, 745-756. https://doi.org/10.1016/0002-9343(80)90267-3
|
[18]
|
Shi, X., Peng, Y., Du, X., et al. (2017) Estradiol Promotes Epithelial-to-Mesenchymal Transition in Human Benign Prostatic Epithelial Cells. The Prostate, 77, 1424-1437. https://doi.org/10.1002/pros.23404
|
[19]
|
Alonso-Magdalena, P., Brössner, C., Reiner, A., et al. (2009) A Role for Epithelial-Mesenchymal Transition in the Etiology of Benign Prostatic Hyperplasia. Proceedings of the National Academy of Sciences of the United States of America, 106, 2859-2863. https://doi.org/10.1073/pnas.0812666106
|
[20]
|
De Nunzio, C., Roehrborn, C.G., Andersson, K.-E. and McVary, K.T. (2017) Erectile Dysfunction and Lower Urinary Tract Symptoms. European Urology Focus, 3, 352-363. https://doi.org/10.1016/j.euf.2017.11.004
|
[21]
|
Gacci, M., Eard-ley, I., Giuliano, F., et al. (2011) Critical Analysis of the Relationship between Sexual Dysfunctions and Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia. European Urology, 60, 809-825.
https://doi.org/10.1016/j.eururo.2011.06.037
|
[22]
|
Yassin, A., Saad, F., Hoesl, C.E., et al. (2006) Al-pha-Adrenoceptors Are a Common Denominator in the Pathophysiology of Erectile Function and BPH/LUTS—Implications for Clinical Practice. Andrologia, 38, 1-12.
https://doi.org/10.1111/j.1439-0272.2006.00709.x
|
[23]
|
Vuichoud, C. and Loughlin, K.R. (2015) Benign Prostatic Hyperplasia: Epidemiology, Economics and Evaluation. The Canadian Journal of Urology, 22, 1-6.
|
[24]
|
Mirone, V., Sessa, A., Giuliano, F., et al. (2011) Current Benign Prostatic Hyperplasia Treatment: Impact on Sexual Function and Management of Related Sexual Adverse Events. International Journal of Clinical Practice, 65, 1005-1013.
https://doi.org/10.1111/j.1742-1241.2011.02731.x
|
[25]
|
Roehrborn, C. G., Barkin, J., Gange, S. N., et al. (2017) Five Year Results of the Prospective Randomized Controlled Prostatic Urethral L.I.F.T. Study. The Canadian Journal of Urology, 24, 8802-8813.
|
[26]
|
McNicholas, T.A., Woo, H.H., Chin, P.T., et al. (2013) Minimally Invasive Prostatic Urethral Lift: Surgical Technique and Multinational Experience. European Urology, 64, 292-299. https://doi.org/10.1016/j.eururo.2013.01.008
|
[27]
|
Sønksen, J., Barber, N.J., Speakman, M.J., et al. (2015) Pro-spective, Randomized, Multinational Study of Prostatic Urethral Lift Versus Transurethral Resection of the Prostate: 12-Month Results from the BPH6 Study. European Urology, 68, 643-652. https://doi.org/10.1016/j.eururo.2015.04.024
|
[28]
|
Shore, N. (2015) A Review of the Prostatic Urethral Lift for Lower Urinary Tract Symptoms: Symptom Relief, Flow Improvement, and Preservation of Sexual Function in Men with Benign Prostatic Hyperplasia. Current Bladder Dysfunction Reports, 10, 186-192. https://doi.org/10.1007/s11884-015-0296-5
|
[29]
|
McVary, K.T., Gange, S.N., Gittelman, M.C., et al. (2016) Mini-mally Invasive Prostate Convective Water Vapor Energy Ablation: A Multicenter, Randomized, Controlled Study for the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia. The Journal of Urology, 195, 1529-1538.
https://doi.org/10.1016/j.juro.2015.10.181
|
[30]
|
McVary, K.T., Rogers, T. and Roehrborn, C.G. (2019) Rezūm Water Vapor Thermal Therapy for Lower Urinary Tract Symptoms Associated with Benign Prostatic Hyperplasia: 4-Year Results from Randomized Controlled Study. Urology, 126, 171-179. https://doi.org/10.1016/j.urology.2018.12.041
|
[31]
|
Gilling, P., Reuther, R., Kahokehr, A. and Fraundorfer, M. (2016) Aquablation—Image-Guided Robot-Assisted Waterjet Ablation of the Prostate: Initial Clinical Experience. BJU International, 117, 923-929.
https://doi.org/10.1111/bju.13358
|
[32]
|
Gilling, P., Barber, N., Bidair, M., et al. (2018) WATER: A Double-Blind, Randomized, Controlled Trial of Aquablation® vs Transurethral Resection of the Prostate in Benign Prostatic Hyperplas-ia. The Journal of Urology, 199, 1252-1261. https://doi.org/10.1016/j.juro.2017.12.065
|
[33]
|
Gilling, P., Barber, N., Bidair, M., et al. (2019) Two-Year Outcomes after Aquablation Compared to TURP: Efficacy and Ejaculatory Improve-ments Sustained. Advances in Therapy, 36, 1326-1336.
https://doi.org/10.1007/s12325-019-00952-3
|
[34]
|
Abt, D., Hechelhammer, L., Müllhaupt, G., Markart, S., et al. (2018) Comparison of Prostatic Artery Embolisation (PAE) versus Transurethral Resection of the Prostate (TURP) for Benign Prostatic Hyperplasia: Randomised, Open Label, Non-Inferiority Trial. BMJ, 361, Article No. k2338. https://doi.org/10.1136/bmj.k2338
|
[35]
|
Pisco, J.M., Bilhim, T., Pinheiro, L.C., et al. (2016) Medium- and Long-Term Outcome of Prostate Artery Embolization for Patients with Benign Prostatic Hyperplasia: Results in 630 Pa-tients. Journal of Vascular and Interventional Radiology, 27, 1115-1122. https://doi.org/10.1016/j.jvir.2016.04.001
|
[36]
|
Bortnick, E., Brown, C., Simma-Chiang, V. and Kaplan, S.A. (2020) Modern Best Practice in the Management of Benign Prostatic Hyperplasia in the Elderly. Therapeutic Advances in Urol-ogy, 12, Article ID: 1756287220929486.
https://doi.org/10.1177/1756287220929486
|
[37]
|
Huang, S.W., Tsai, C.Y., Tseng, C.S., et al. (2019) Comparative Efficacy and Safety of New Surgical Treatments for Benign Prostatic Hyperplasia: Systematic Review and Network Me-ta-Analysis. BMJ, 367, Article No. l5919.
https://doi.org/10.1136/bmj.l5919
|
[38]
|
Magistro, G., Chapple, C.R., Elhilali, M., et al. (2017) Emerging Minimally Invasive Treatment Options for Male Lower Urinary Tract Symptoms. European Urology, 72, 986-997. https://doi.org/10.1016/j.eururo.2017.07.005
|